MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 129 filers reported holding MERSANA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 297.00 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,125,278 | -61.4% | 7,972,660 | +0.1% | 0.00% | -100.0% |
| Q2 2023 | $26,201,501 | -14.7% | 7,963,982 | +6.6% | 0.00% | 0.0% |
| Q1 2023 | $30,717,406 | -30.0% | 7,473,822 | -0.2% | 0.00% | 0.0% |
| Q4 2022 | $43,902,704 | -8.4% | 7,491,929 | +5.7% | 0.00% | -50.0% |
| Q3 2022 | $47,916,000 | +16.8% | 7,088,087 | -20.2% | 0.00% | +100.0% |
| Q2 2022 | $41,030,000 | +34.8% | 8,881,019 | +16.5% | 0.00% | 0.0% |
| Q1 2022 | $30,427,000 | -34.6% | 7,626,196 | +2.0% | 0.00% | 0.0% |
| Q4 2021 | $46,520,000 | -44.0% | 7,479,229 | -15.1% | 0.00% | -50.0% |
| Q3 2021 | $83,055,000 | -30.7% | 8,807,328 | -0.2% | 0.00% | -33.3% |
| Q2 2021 | $119,814,000 | -7.5% | 8,822,704 | +10.3% | 0.00% | -25.0% |
| Q1 2021 | $129,472,000 | -39.1% | 8,002,086 | +0.2% | 0.00% | -42.9% |
| Q4 2020 | $212,556,000 | +57.4% | 7,987,812 | +10.1% | 0.01% | +40.0% |
| Q3 2020 | $135,031,000 | -19.2% | 7,252,006 | +1.6% | 0.01% | -28.6% |
| Q2 2020 | $167,023,000 | +771.7% | 7,137,740 | +117.2% | 0.01% | +600.0% |
| Q1 2020 | $19,160,000 | +35.6% | 3,286,479 | +33.3% | 0.00% | 0.0% |
| Q4 2019 | $14,126,000 | +267.6% | 2,465,319 | +1.4% | 0.00% | – |
| Q3 2019 | $3,843,000 | -60.3% | 2,431,743 | +1.7% | 0.00% | – |
| Q2 2019 | $9,681,000 | +105.0% | 2,390,463 | +166.2% | 0.00% | – |
| Q1 2019 | $4,723,000 | +48.2% | 897,845 | +14.9% | 0.00% | – |
| Q4 2018 | $3,187,000 | -68.9% | 781,128 | -23.8% | 0.00% | – |
| Q3 2018 | $10,250,000 | -43.0% | 1,025,042 | +1.9% | 0.00% | -100.0% |
| Q2 2018 | $17,973,000 | +39.3% | 1,006,357 | +23.0% | 0.00% | 0.0% |
| Q1 2018 | $12,899,000 | +36.0% | 818,004 | +41.7% | 0.00% | – |
| Q4 2017 | $9,485,000 | +108.0% | 577,299 | +118.9% | 0.00% | – |
| Q3 2017 | $4,561,000 | – | 263,783 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 4,005,600 | $64,810,000 | 6.21% |
| Bain Capital Life Sciences Investors, LLC | 3,695,667 | $59,796,000 | 3.39% |
| COMMODORE CAPITAL LP | 429,228 | $6,945,000 | 2.77% |
| ACUTA CAPITAL PARTNERS, LLC | 357,689 | $5,787,000 | 2.09% |
| Avoro Capital Advisors LLC | 6,800,000 | $110,024,000 | 1.90% |
| Ghost Tree Capital, LLC | 450,000 | $7,281,000 | 1.71% |
| RHO CAPITAL PARTNERS INC | 796,458 | $12,887,000 | 1.24% |
| Rock Springs Capital Management LP | 2,775,127 | $44,902,000 | 0.98% |
| Sio Capital Management, LLC | 157,259 | $2,544,000 | 0.52% |
| Bellevue Group AG | 2,850,010 | $46,113,000 | 0.49% |